Ginkgo Bioworks Holdings, Inc. (DNA)
Fuera de horario:
Ginkgo Bioworks Holdings, Inc.
27 Drydock Avenue
8th Floor
Boston, MA 02210
United States
877 422 5362
https://www.ginkgobioworks.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 1,218
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. Jason Kelly | Founder, CEO & Director | 262.5k | N/D | 1982 |
| Dr. Reshma P. Shetty | Founder, President, COO & Director | 262.5k | N/D | 1982 |
| Mr. Mark E. Dmytruk | Chief Financial Officer | 465.25k | N/D | 1972 |
| Mr. Thomas Knight Jr. | Founder | N/D | N/D | N/D |
| Mr. Bartholomew Canton | Founder, CTO & Secretary | N/D | N/D | N/D |
| Mr. Steven P. Coen CPA | Chief Accounting Officer | N/D | N/D | N/D |
| Karen Tepichin | General Counsel & Secretary | N/D | N/D | N/D |
| Ms. Anna Marie Wagner | Senior Vice President of Corporate Development | N/D | N/D | N/D |
| Ms. Samantha Sutton | Head of People | N/D | N/D | N/D |
| Mr. Joshua Dunn | Head of Design | N/D | N/D | N/D |
Descripción
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Gestión corporativa
La calificación ISS Governance QuickScore de Ginkgo Bioworks Holdings, Inc. a partir del 1 de abril de 2024 es 10. Las puntuaciones principales son Auditoría: 9; Junta: 6; Derechos del accionista: 10; Compensación: 9.
